Current research projects advancing regulatory science at the intersection of biodiversity, biosafety, and biotechnology.
We're active partners in EU-funded research projects, keeping us at the forefront of emerging regulatory frameworks and scientific developments.
BlueRemediomics is an innovative European project uniting 25 partners from 13 countries delving into the ocean's untapped marine microbial communities to boost the European blue economy. The project will establish a bioinformatics platform and cutting-edge culturomics to discover and develop marine microbial products, focusing on sustainability and equitable resource access. Bridging discovery with application, BlueRemediomics is set to accelerate product development and set new standards in marine biodiscovery, balancing ecological stewardship with intellectual property rights.
Horizon 2020
MARBLES is a groundbreaking €7.5 million project, spanning five years with support from the EU, set to make waves in the world of sustainable bioprospecting. By exploring the untapped wealth of marine microbes, MARBLES aims to discover new bioactive compounds and microbial consortia that could revolutionize aquaculture, farming, and healthcare. With cutting-edge genomics and novel bioactive-compounds elicitors, MARBLES promises not just to unveil new environmentally friendly solutions for disease control but also to align with key UN goals, marking a new chapter in our quest for sustainable industry solutions.
Horizon 2020
NYMPHE develops innovative bioremediation and plant health solutions using novel microorganisms and bioactive compounds. The project integrates biosafety assessment, regulatory compliance, and risk management from early research stages through to commercialization. 3BIO provides comprehensive regulatory guidance, ensuring all research activities comply with biosafety regulations, GMO directives, and environmental release requirements across multiple EU jurisdictions.
Marie Curie Doctoral Network
The HOTBIO consortium trains a new generation of scientists in transforming marine microbial natural products from deep-sea discoveries to medical applications. Involving 11 PhD students hosted by 10 European beneficiaries, the program covers all stages of the drug development pipeline – from microbial isolation and compound purification to creating drug-like analogues. The training includes skills in access and benefit-sharing, intellectual property, and entrepreneurship, preparing graduates for the competitive labour market with multidisciplinary experience in academic and industrial settings, supported by mentorship from industry experts and MSCA ITN MarPipe alumnae.
The SEAWEEDforBangladesh project, backed by the Dutch Embassy in Dhaka and led by 3BIO, represents a significant step in harnessing the Bay of Bengal's rich seaweed diversity for Bangladesh's emerging blue biotechnology sector. With over 220 native seaweed species in Bangladesh, 3BIO's marine genetic resources scoping study has paved the way for sustainable seaweed cultivation, simultaneously boosting environmental health and bolstering coastal resilience. The project also explored seaweed's versatile applications across industries like animal feed, cosmetics, and bioremediation, propelling Bangladesh towards a sustainable blue economy and setting a precedent in marine genetic resource utilization.